Uncovering Potential: Aurinia Pharmaceuticals's Earnings Preview

Aurinia Pharmaceuticals AUPH will release its quarterly earnings report on Monday, 2025-05-12. Here's a brief overview for investors ahead of the announcement.

Analysts anticipate Aurinia Pharmaceuticals to report an earnings per share (EPS) of $0.10.

The announcement from Aurinia Pharmaceuticals is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.

It's worth noting for new investors that guidance can be a key determinant of stock price movements.

Historical Earnings Performance

In the previous earnings release, the company beat EPS by $0.03, leading to a 5.3% increase in the share price the following trading session.

Here's a look at Aurinia Pharmaceuticals's past performance and the resulting price change:

Market Performance of Aurinia Pharmaceuticals's Stock

Shares of Aurinia Pharmaceuticals were trading at $8.11 as of May 08. Over the last 52-week period, shares are up 61.25%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Aurinia Pharmaceuticals visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.